← All patents

US20230024933A1

Treatment of aberrant fibroblast proliferation

University of Texas System

Abstract

Provided is a method of preventing, treating or delaying progression of a disease involving aberrant fibroblast proliferation. The method involves using a compound that reduces the level of tyrosine phosphatase activity effected by the protein EYA1A in the parenchymal organ, a nucleic acid ligase …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Michael ZEISBERG
Priority date
November 08, 2019
Filing date
April 06, 2022
Publication date
January 26, 2023
Language
en
Metadata fetched
August 29, 2026 00:30